Dimethyl (3aR,8aR)-8a-methyl-4-methylidene-1,2,3,3a,5,8-hexahydroazulene-2,6-dicarboxylate
C16H22O4 — CID 135054204
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dimethyl (3aR,8aR)-8a-methyl-4-methylidene-1,2,3,3a,5,8-hexahydroazulene-2,6-dicarboxylate
Dimethyl (3aR,8aR)-8a-methyl-4-methylidene-1,2,3,3a,5,8-hexahydroazulene-2,6-dicarboxylate (PubChem CID 135054204) has the molecular formula C16H22O4 and a molecular weight of 278.35 g/mol. Its IUPAC name is dimethyl (3aR,8aR)-8a-methyl-4-methylidene-1,2,3,3a,5,8-hexahydroazulene-2,6-dicarboxylate.
Molecular Properties
| Compound Name | Dimethyl (3aR,8aR)-8a-methyl-4-methylidene-1,2,3,3a,5,8-hexahydroazulene-2,6-dicarboxylate |
|---|---|
| PubChem CID | 135054204 |
| Molecular Formula | C16H22O4 |
| Molecular Weight | 278.35 g/mol |
| Exact Mass | 278.15 |
| IUPAC Name | dimethyl (3aR,8aR)-8a-methyl-4-methylidene-1,2,3,3a,5,8-hexahydroazulene-2,6-dicarboxylate |
| SMILES | C=C1CC(C(=O)OC)=CC[C@]2(C)CC(C(=O)OC)C[C@H]12 |
| InChI | InChI=1S/C16H22O4/c1-10-7-11(14(17)19-3)5-6-16(2)9-12(8-13(10)16)15(18)20-4/h5,12-13H,1,6-9H2,2-4H3/t12?,13-,16-/m1/s1 |
| InChIKey | QOPYIGQOALVJTN-LLQOJDTPSA-N |
| XLogP | 2.64 |
| TPSA | 52.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 278.35 |
| LogP ≤ 5 | 2.64 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135054204 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.